• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. HEALON ENDOCOAT; OVDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. HEALON ENDOCOAT; OVDS Back to Search Results
Model Number HEALON ENDOCOAT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Inflammation (1932)
Event Date 08/07/2020
Event Type  Injury  
Manufacturer Narrative
Sex/gender: unknown/ not provided.If implanted; give date: n/a (not applicable).The healon endocoat is not an implantable device.If explanted; give date: n/a (not applicable).The healon endocoat is not an implantable device.Concomitant medical products: intraocular lens, model zcb00, balanced salt solution (bss) irrigation solution, prol ystica, quick rinse.Phone number: unknown/ not provided.Other: the device is not returning for evaluation as it was discarded by the account; therefore, a failure analysis of the complaint device cannot be completed.A review of the device/lot history record and complaint trending for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
It was reported that toxic anterior segment syndrome (tass) occurred in the left eye of a patient.Besivance ophthalmic eye drops 3x daily for 1 week (normal post cataract order) was prescribed to the patient.It was indicated that the was a severe inflammation; however, the patient has recovered.The lens remains in the patient's eye.No further information was provided.This emdr report is for the healon endocoat device.A separate emdr is being submitted for the intraocular lens, model zcb00.
 
Manufacturer Narrative
Additional information received from customer, indicated the patient was a female and that the post-op drops given to the patient were ofloxacin, lotemax and prolenza.The following fields were updated accordingly: section a3: sex/gender: female; section b2: outcomes attributed to adverse event: required intervention; section d11: concomitant medical products: phaco machine, sn unknown, phaco disposable tubing, lot unknown.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEALON ENDOCOAT
Type of Device
OVDS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key11042220
MDR Text Key222620964
Report Number3004750704-2020-00074
Device Sequence Number1
Product Code LZP
UDI-Public(01)(17)220131(10)028551
Combination Product (y/n)Y
PMA/PMN Number
P110007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 01/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2022
Device Model NumberHEALON ENDOCOAT
Device Catalogue Number57502000
Device Lot Number028551
Was Device Available for Evaluation? No
Date Manufacturer Received12/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age76 YR
-
-